Literature DB >> 7588939

Myocardial technetium-99m sestamibi single-photon emission tomography as a prognostic tool in coronary artery disease: multivariate analysis in a long-term prospective study.

P Zanco1, A Zampiero, A Favero, N Borsato, F Chierichetti, D Rubello, B Saitta, G Ferlin.   

Abstract

To date several studies have evaluated the accuracy of thallium-201 myocardial scan in risk stratification of coronary artery disease (CAD), while reports using technetium-99m methoxyisobutylisonitrile (MIBI), a tracer particularly suited to single-photon emission tomographic (SPET) imaging, are lacking. To rectify this omission, a prospective study was started in 1988 and at present 176 consecutive, and thus unselected, patients have been enrolled. All of them have been submitted to stress-rest MIBI SPET for the diagnosis or evaluation of CAD; 147 patients (121 males and 26 females, aged 53 +/- 9 years) have completed a surveillance period of at least 36 months following the scintigraphic study (range 36-60 months, mean 43). Sixty-one patients had a documented previous myocardial infarction. The mean pre-test likelihood of CAD was 44% in the patients without prior infarction. The main anamnestic, clinical, EKG and scintigraphic findings were evaluated and statistically correlated with the incidence of ensuing cardiac events using both univariate (chi-square test) and multivariate analysis (logistic regression model). Twenty-nine patients suffered from a cardiac event during the follow-up period (i.e. three cardiac deaths, six myocardial infarctions and 20 cases of unstable angina). Statistical multivariate analysis identified MIBI scan as the only highly significant and independent prognostic predictor [P = 0.006, relative risk (RR) = 17.62]. In detail, the most important scintigraphic parameters were the presence of a reversible defect (P = 0.0089, RR = 5.11) and the extension of the stress perfusion defect (P = 0.0255, RR = 3.27). The presence of typical angina proved to be a slightly significant predictor (P = 0.051, RR = 2.45), while no other examined parameter showed a significant correlation with a bad prognosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588939     DOI: 10.1007/BF00808414

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  12 in total

Review 1.  Technetium 99m sestamibi in the assessment of chronic coronary artery disease.

Authors:  D S Berman; H Kiat; K Van Train; E Garcia; J Friedman; J Maddahi
Journal:  Semin Nucl Med       Date:  1991-07       Impact factor: 4.446

2.  Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Validation of models based on these tests.

Authors:  S G Pollock; R D Abbott; C A Boucher; G A Beller; S Kaul
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

3.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease.

Authors:  G A Diamond; J S Forrester
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

4.  Prognostic value of thallium-201 stress myocardial scintigraphy with exercise ECG after myocardial infarction.

Authors:  J P Smeets; P Rigo; V Legrand; M Chevigné; F Hastir; H E Kulbertus
Journal:  Cardiology       Date:  1981       Impact factor: 1.869

5.  Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events.

Authors:  D D Miller; H G Stratmann; L Shaw; B R Tamesis; M D Wittry; L T Younis; B R Chaitman
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

6.  Comparative value of maximal treadmill testing, exercise thallium myocardial perfusion scintigraphy and exercise radionuclide ventriculography for distinguishing high- and low-risk patients soon after acute myocardial infarction.

Authors:  J Hung; M L Goris; E Nash; H C Kraemer; R F DeBusk; W E Berger; H Lew
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

7.  Prognostic value of normal technetium-99m-sestamibi cardiac imaging.

Authors:  K A Brown; E Altland; M Rowen
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

8.  Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain.

Authors:  H G Stratmann; G A Williams; M D Wittry; B R Chaitman; D D Miller
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

Review 9.  Myocardial scintigraphy--25 years after start.

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1988

10.  Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography.

Authors:  R S Gibson; D D Watson; G B Craddock; R S Crampton; D L Kaiser; M J Denny; G A Beller
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

View more
  9 in total

1.  The prognostic value of myocardial perfusion scintigraphy: investigators, are you (mis)leading us?

Authors:  J J Borm; H Bouwsma; E E van der Wall; E K Pauwels
Journal:  Eur J Nucl Med       Date:  2001-09

2.  Risk stratification using line source attenuation correction with rest/stress Tc-99m sestamibi SPECT myocardial perfusion imaging.

Authors:  Afrooz Ardestani; Alan W Ahlberg; Deborah M Katten; Krista Santilli; Donna M Polk; Timothy M Bateman; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-11-21       Impact factor: 5.952

3.  Increased prognostic value of combined myocardial perfusion imaging and exercise electrocardiography in patients with coronary artery disease.

Authors:  B Zerahn; B V Jensen; K D Nielsen; S Møller
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

4.  Accuracy of exercise stress technetium 99m sestamibi SPECT imaging in the evaluation of the extent and location of coronary artery disease in patients with an earlier myocardial infarction.

Authors:  A Elhendy; F B Sozzi; R T van Domburg; J J Bax; M L Geleijnse; R Valkema; E P Krenning; J R Roelandt
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

5.  Long-term prognosis after a normal exercise stress Tc-99m sestamibi SPECT study.

Authors:  Abdou Elhendy; Arend Schinkel; Jeroen J Bax; Ron T van Domburg; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

6.  Prognostic evaluation of patients after myocardial infarction: incremental value of sestamibi single-photon emission computed tomography and echocardiography.

Authors:  P Zanco; A Zampiero; A Favero; N Borsato; F Chierichetti; D Rubello; G Ferlin
Journal:  J Nucl Cardiol       Date:  1997 Mar-Apr       Impact factor: 5.952

7.  Risk stratification with attenuation corrected stress Tc-99m sestamibi SPECT myocardial perfusion imaging in the absence of ECG-gating due to arrhythmias.

Authors:  Sarkis B Baghdasarian; Gavin L Noble; Alan W Ahlberg; Deborah Katten; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2009-03-14       Impact factor: 5.952

8.  Perioperative and long-term prognostic value of dipyridamole Tc-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery.

Authors:  Mylan C Cohen; Andrea E Siewers; John D Dickens; Thomas Hill; James E Muller
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

9.  Long-term prognostic value of exercise 99mTc-MIBI SPET myocardial perfusion imaging in patients after percutaneous coronary intervention.

Authors:  Xiaoli Zhang; Xiujie Liu; Zuo-Xiang He; Rongfang Shi; Minfu Yang; Runlin Gao; Jilin Chen; Yuejin Yang; Wei Fang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-22       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.